These data indicate that downregulation of MAPT and upregulation of GBA, CCDC62, HIP1R, and perhaps BDNF and DRD2 may reduce PD risk, reflected in Table 1, whereas the effects of transcription regulation of the other genes on PD risk are more tentative. The gene discussed is DRD2; the disease is Parkinson disease.